Plasma doping: Progress and potential (Part one of two)
09/01/1999
Abstract
Beam-line ion implantation, the pre-eminent doping method in silicon, is being pushed to the limit by the need to fabricate ultra-shallow junctions. Plasma doping is envisaged to be the alternative technique suited for the shift to simpler, more economical, higher throughput, and cluster-compatible hardware. The technology has gained much momentum in the past several years and an international plasma doping users group has been formed to bring together equipment manufacturers, process engineers, and researchers. In this article (part one of two parts), we will review the current status of plasma doping, present the latest device data, and discuss process and equipment issues.
In this article: |
---|
Ultra-shallow junction formation by PD |
Process-related issues |
References |
P. Kellerman, F. Sinclair, Eaton Corp., Beverly, Massachusetts, L.A. Larson, Sematech, Austin, Texas,
B. Mizuno, Matsushita Electric Industrial Co. Ltd., Moriguchi, Osaka, Japan
Ultra-shallow junctions are required for deep sub-micro meter integrated circuits in the 21st century. The most logical fabrication method is to extend the beam-line ion implantation technology to ultra-low energies. Even though low-energy beam-line ion implantation has been demonstrated [1-3], it suffers from slow throughput.
Several alternative techniques have been proposed, including plasma doping (PD) [4-11], high-temperature rapid vapor doping (RVD) [12, 13], room-temperature vapor doping [14], and gas immersion laser doping (GILD) [15, 16]. Plasma implantation methods - PD, plasma assisted doping (PLAD), and plasma immersion ion implantation (PIII) - have been regarded as the most promising candidates to obtain ultra-shallow doping profiles due to low implantation energy, high throughput, low machine cost, room temperature operation, and compatibility to a CMOS production environment.
Figure 1. Cross section schematic of the 0.17?m PMOSFET. |
When the 1997 National Technology Roadmap for Semiconductors was issued, PD was clearly listed as the leading candidate among several for the alternative doping method to compete with low-energy beam-line ion implantation (II). Here we describe the current status of PD, process and equipment issues, and the outlook of PD as a replacement for beam-line ion implantation in the fabrication of ultra-shallow junctions.
Ultra-shallow junction formation by PD
PD can be implemented in three different configurations: gas source PD, solid source PD (SPD), and RVD with plasma pre-treatment. SPD is gaining popularity as the use of toxic dopant gases can be eliminated. Gas source PD is usually performed in a B2H6 plasma diluted by He sustained by an electron cyclotron (ECR) or radio frequency (RF) plasma source. The aim of dilution is to control the implantation rate and toxic dopant species. The wafer is attached to a sample holder or chuck acting as the cathode. When a bias of several hundred volts is applied to the sample chuck, positive ions are implanted into the wafer at the applied voltage assuming a collisionless condition (plasma sheath thickness < ion mean free path). Contrary to beam-line ion implantation, the entire wafer is implanted simultaneously, and the implantation time is independent of the wafer dimension so cost does not go up with wafer size.
Figure 1 depicts the cross section of a device in which the source/drain extensions are formed by PD (0.5% B2H6/He, 100 sec) and with low-energy ion implantation (5keV, BF2, 6x1013cm-2) for the control. The gate electrodes and source/drain electrodes are also formed by PD (5% B2H6/He, 100 sec) [5].
Figure 2. SIMS depth profiles of PD junction (as implanted, annealed) and a 2keV beam-line implant; ii=ion implant; PD=plasma doping. |
null
The SIMS (secondary ion mass spectrometry) depth profiles of the as-implanted (5% B2H6/He, 100 sec) and annealed (1000°C, 10 sec) samples are shown in Fig. 2. For comparison, the boron depth profile of a 2keV as-implanted beam-line sample is overlaid. The PD profiles show a higher surface boron concentration compared to the beam-line profile due to surface chemisorption. The as-implanted PD profile has a junction depth of 25nm whereas it is 50nm for the annealed PD sample.
Device characteristics and yield. The device performance of PMOSFETs fabricated by industrial CMOS processes at both AMD and CNET using PD is excellent. AMD has found in general that PMOS devices fabricated by PD exhibit subthreshold swing, off-state leakage, and hot-carrier reliability similar to the beam-line ones. Also, higher drive currents are observed in the plasma-doped devices. These improvements can be attributed to the reduced source/drain resistance and higher inversion gate capacitance due to better activation with PD. CNET has found that the electrical results (especially the normalized ion for deep sub-micrometer PMOSFETs) are better than those obtained with standard BF2+ implantation. Other parameters improve due to the reduced lateral diffusion. Finally, the oxide reliability improves when the extensions are plasma doped.
Another device study by Samsung [17] compares MOSFETs where the source/drain/gate and shallow source/drain extension are fabricated by BF3 PD with those formed employing BF2 beam-line II. It is found that the gate oxide reliability, drain current, and transconductance of the PMOSFETs are remarkably improved. Cobalt salicide formation is also found to be compatible with plasma-doped source/drain junctions. Also, no evidence of plasma damage or fluorine-induced gate oxide reliability degradation has been detected in the PD samples.
Figure 3. Subthreshold characteristics of 0.17µm PMOSFET fabricated by PD. |
null
As an example, the subthreshold characteristics of the 0.17µm PMOS fabricated in Matsushita [5] are shown in Fig. 3. The sub-threshold slope of 89mV/decade for the PD sample matches that of 5keV beam-line BF2 implantation.
Figure 4. Comparison of I-V characteristics of a) beam-line doped and b) PD junctions. |
null
Figure 5. Yield comparison among gas source plasma doping (PD), solid source plasma doping (SPD), and beam-line ion implantation (II). |
null
The I-V characteristics shown in Fig. 4 are also excellent. The PD sample has higher drain current than the beam-line one, as demonstrated by the higher saturation currents. Recently, Samsung [17], Micron, French Telecom [18], AMD, Varian [19], and Matsushita [20] have demonstrated that plasma-doped MOSFETs show higher transconductance and carrier activation efficiency in sub-0.18µm devices. Trench doping for DRAM capacitor cells has also been shown by Siemens-IBM [18]. The yield of 256kb SRAM structures fabricated by PD and beam-line II has been compared. As shown in Fig. 5, the yields of gas source PD, SPD, and beam-line II are comparable [21].
Throughput and sur face metal contamination. Aside from the low energy, the other significant advantage of PD is its high throughput. For beam-line II, the maxi-mum beam current density for the whole wafer area is about 7µA/cm2 (5mA boron beam at 3keV for a 300mm wafer). How-ever, it is about 3mA/ cm2 for plasma doping. One can therefore ex-pect a 400x improvement in the throughput in the 300mm wafer age.
Figure 6. Comparison of Al, Fe, Zn, Mg surface concentrations on three PD samples vs. a beam-line ion implanted sample. |
null
Figure 6 compares the surface metal contamination on PD and beam-line implanted samples. The surface Al, Fe, Zn, and Mg concentrations on the three PD samples are comparable to those on the beam-line implanted wafer [21], further illustrating the viability of PD. These and other process related issues will be discussed in more detail in the next section.
Process-related issues
PD promises enormous productivity improvements so it is attractive to manufacturing managers, but adoption will be blocked unless it can demonstrate yield and consistent process control. Control implies both an ability to tailor the doping profile to fit a particular requirement derived from a device model (theoretical predictability) and the capability to execute the same process every day in a manufacturing environment (practical reproducibility).
Theoretical predictability. One of the great strengths of conventional beam-line II is its excellent theoretical predictability over a wide range of process conditions. Such an implanter has three principal controls: species, energy, and dose. Each of these parameters is mapped directly to the device physicists' models. The species selected by the mass analysis magnet defines the ratio of the atomic or molecular ion mass to its charge state over about two orders of magnitude. The energy is defined by the accelerating voltage over three orders of magnitude and can be used to calculate the doping profile according to models that have been under intensive development over the last three decades and are now very accurate for all but the most extreme energies. The dose maps directly to the concentration, allowing proportional control over six orders of magnitude.
Plasma doping has a long way to go before it can match beam-line II in terms of theoretical predictability. The as-implanted junction depth is primarily determined by the pulse voltage and has been shown to vary linearly with this voltage over a range from 0.14-5 kV [22]. However, in PD, all ionized species in the plasma are implanted. For example, with BF3 gas, the predominant ions implanted are BF2+, B+, and F+. Furthermore, the energy spectrum of the ions contains components lower than the pulse voltage due to ions present in the sheath at the onset and turn off of the pulse, as well as because of the finite rise and fall times of the pulse. While low-energy ions are not detrimental (even preferred) in shallow junction formation, both of these factors can affect the dopant depth profile. They offer the process engineer new opportunites for tailoring this profile, being of particular use for shallow junctions [23-25]. PD has also been shown to satisfy the 1997 SIA National Technology Roadmap requirements at the 100nm node for source/drain extensions, where annealed junction depths must be <40nm and the activated surface dopant concentration must be above 1x1020 atoms/cm3 [26].
Although PD's new multidimensional richness may offer process advantages, it also creates many challenges for the equipment manufacturer. Parameters typically monitored on PD tools at this time can only be indirectly mapped to process results. Plasma source parameters, such as pressure and power, can only be coupled to plasma ion fractions by complex models [27, 28]. The total current measured from the platen is only indirectly related to the ion current due to the presence of secondary electron and displacement currents (current needed to charge the platen to its pulsed voltage) [29]. Process engineers must resort to relating these machine controllable parameters directly to implant profiles (provided by SIMS measurements, for example), and then use models to interpolate between values. Clearly, more work is needed to improve the predictive capability in PD. Besides improving the models, further instrumentation may be required, such as Faraday cups, emission spectrophotometers, and ion mass spectrometers.
Practical reproducibility. Once a process engineer has defined the process that achieves the required sheet resistance, Rs, and junction depth, xj, for the optimal device performance, attention shifts to repeating the process in routine manufacturing. The early stages of process qualification will often include small adjustments to the process control parameters to home in on specific device parameters. Thus, it is important that repeated runs under the same conditions produce results that have as small a variability as possible. In addition, it is critical that the relationships between tool parameter setting and device characteristics are continuous and well-behaved functions that allow rapid convergence on the settings for a desired outcome given simple heuristic models. Long-term repeatability is crucial for consistent device yield over the lifetime of the manufacturing process.
null
Besides the pulsing, the major factors that affect the dose and depth of an implant are the density and composition of the plasma. While there may be details that are determined by the specific excitation mechanism, most data show that the plasma temperature determines the molecular dissociation and the ion charge state. Plasma temperature in turn is controlled by gas pressure and total power coupled into the plasma. These also control the plasma density. Dose and energy profile are then determined by the pulse parameters. Effective accelerating voltage is determined by pulse amplitude and duration and how these interact with plasma density to determine plasma sheath expansion and thus energy and range of the ions when they impinge on the wafer surface. The final dose is determined by species composition, pulse characteristics, and num ber of pulses. The relationship be tween machine parameters and Rs and xj is complex, and is depicted in Fig. 7.
However complex this chain of relationships, though, if it were complete, one would still expect that accurate control of machine parameters would lead to repeatable Rs and xj. Unfortunately, this picture is not complete. As with all implanters, other sources of variation are beyond our direct control. Thus, implanters require an active feedback dosimetry system to maintain repeatability. Even though PD is simpler than beam-line II, one would still expect to require some form of active dose control.
The simplest component of a dosimetry system for PD - the ion dose control - can be accomplished by determining the dose per pulse and then using that to control the number of pulses. Ion dose rate can be determined by measuring current to the platen (and modeling) or using a Faraday cup. However, the dopant dose is also dependent on the ratio of the dopant ions in the plasma. The hope is that this ratio remains stable, provided the source parameters (pressure and power) are held constant. However, stabilizing the plasma conditions might require further plasma diagnostics. At the simplest level, a Langmuir probe might be used, although this carries a risk of perturbing what it is trying to measure, and is a potential source of metal contamination. Another possibility is a mass spectrometer that could measure the ions emerging from the plasma at the boundaries. Finally, one might consider an optical spectrometer as a method to fingerprint a given plasma condition [30]. This could be used in closed loop to control the plasma source, or to at least compensate for an ion fraction change when controlling the number of pulses.
Besides the reproducibility from one wafer to the next, that from one point on the wafer to another (uniformity) is a key equipment design objective. All PD systems in development are aimed at processing wafers up to 300mm, presenting a significant challenge to the design of the plasma confinement system and other process chamber features. Conventional ion implant systems have traditionally offered 1s dose uniformities of 0.5%. Actual requirements are set by yield limits on devices. Data so far show that 1s uniformities of 1.1% have been obtained for selected energy ranges with 200mm wafers and that PD is capable of operating within a 5% window for all energies.
Since devices are subject to both within- and between-wafer variations equally, there is a potential trade-off between reproducibility and uniformity, but actually it seems sensible to target a similar value for both. Another subject of debate is the best way to quantify the spread in process conditions. Many workers implicitly assume a normal distribution and quote either 1s or 3s values as deviations from the mean. Assuming a normal distribution is probably good for between-wafer reproducibility, but may be seriously in error for within-wafer uniformity. Many tests of PD systems show a characteristic fingerprint from construction of the chamber or the density gradients produced by the plasma excitation system.
We think that at this point of tool maturity, 1s targets of <2% for both uniformity and reproducibility are achievable and represent at least useful performance.
Part two of this article will discuss potential problems with plasma doping, such as charging damage, heating, contamination, equipment design, cost of ownership, and prospects. The Plasma Doping Users Group holds meetings worldwide to improve information exchange. For more information, visit www.cityu.edu.hk/ap/plasmausers/home.htm.
References
- A. Hori, B. Mizuno et al., Tech. Dig. IEDM, 485, 1994.
- Y.V. Ponomarev et al., Tech. Dig. VLSI Symposium, Kyoto, 65, 1999.
- J.M. Ha et al., Tech. Dig. VLSI Symposium, Kyoto, 71, 1999.
- B. Mizuno, I. Nakayama et al., Appl. Phys. Lett, 53, 2059, 1988.
- B. Mizuno, M.Takase et al., Dig. of Symp. VLSI Tech., 66, 1996.
- S. Felch et al., Nucl. Instrm. Meth. Phys. Res., B74, 687, 1993.
- S. Qin, C. Chan, IEEE Trans. Electron Dev., 39, 2354, 1992.
- X.Y. Qin, N.W. Cheung, Nucl. Instr. Meth. Phys. Res., B55, 821, 1991.
- E.C. Jones et al., Electron. Dev. Lett, 14, 444, 1993.
- N.W. Cheung et al., Ext. Abs. SSDM, 351, 1995.
- P.K. Chu, N.W. Cheung, C. Chan, Semiconductor Int. 6, 165, 1996.
- Y. Kiyota et al., Dig. of Symp. on VLSI Tech., 97, 1993.
- T. Uchino et al., Tech. Dig. VLSI Symposium, Kyoto, 93, 1999.
- B. Mizuno, M. Takase et al., Ext. Abs. SSDM, 1041, 1995.
- Applied Physics Review in J. Appl. Phys., vol. 81, 1997.
- SIA Roadmap.
- J. M. Ha et al., Tech. Dig. of IEDM, San Francisco, 639, 1998.
- 4th Plasma Doping Users Group (PDUG) meeting, Boston, April 1999.
- R. B. Liebert et al., Tech. Dig. IIT98, Kyoto, 2, 1998.
- M. Takase, B. Mizuno, et al., IEDM, Washington DC, 475, 1997.
- M. Takase, et al, Int. Sym. Semi. Mfg Conf. Proc., P.B-9, San Francisco, 1997.
- M.J. Goeckner et al., to be published in J. Vac. Sci. Technol. B.
- P.K. Chu et al., Mat. Sci. Eng. Reports, R17, 207, 1996.
- E.C. Jones, N.W. Cheung, J. Vac. Sci. Technol. B, 14(1), 255, 1996.
- J. Shao, E. Jones, N. Cheung, Surf. Coat. Tech., 93, 254, 1997.
- D.F. Downey, S. B. Felch, S.W. Falk, to be published in the Proc. of the RTP Symposium of the May 1999 ECS Conference.
- S. Qin et al., Nucl. Instrum. Meth. Phys. Res. B, 106, 636, 1995.
- M.A. Graf, V. Benveniste, M.A. Lieberman, K. Patel, Proc. of the XII Int. Conf. on Ion Impl. Tech., Kyoto, Japan, 1998.
- E.C. Jones, N.W. Cheung, IEEE Trans. Plasma. Sci., 25(1), 1997.
- M.A. Graf, et al., Proc. of XII Intl. Conf. on Ion Impl. Tech., Kyoto, Japan, 1998.
For more information, contact Paul Chu, Dept. of Physics & Materials Science, City University of Hong Kong, 83 Tat Chee Ave., Kowloon, Hong Kong, ph 852/2788-7724, fax 852/2788-9549, e-mail [email protected].